May 3rd, 2010
Chang S et al. – Before any contact precautions can be implemented, newly identified MRSA carriers frequently have contaminated their environment with MRSA and have contamination of commonly examined skin sites. In hospitals that perform active surveillance, strategies are needed to minimize delays in screening or to preemptively identify patients at high risk for disseminating MRSA
read more
April 23rd, 2010
Jump RLP et al. – To determine whether a multihospital Clostridium difficile outbreak was associated with epidemic strains and whether use of particular fluoroquinolones was associated with increased infection rates, the authors cultured feces from C. difficile–infected patients. Use of fluoroquionolones with enhanced antianaerobic activity was not associated with increased infection rates. read more
April 23rd, 2010
Stevens AM et al. – Skin infections were more likely to develop in MRSA carriers than in methicillin–susceptible S. aureus carriers or noncarriers of S. aureus during the first follow–up year, but not in subsequent years. Repeated skin infections were more common among MRSA carriers. In an area where PVL–containing MRSA is prevalent, skin infection risk was increased among MRSA nasal carriers compared with methicillin–susceptible S. aureus carriers and noncarriers, but risk differential diminished over time. read more
April 14th, 2010
Schaefer MK et al. – Code combinations were better at revealing CO–MRSA infections than HO–MRSA infections. These limitations could compromise the validity of ICD–9–CM codes for interfacility comparisons and for reporting of healthcare–associated MRSA infections.
read more
April 14th, 2010
Achkar JM et al. – Despite its high incidence and clinical relevance, genitourinary candidiasis is understudied, and therefore, important questions about pathogenesis and treatment guidelines remain to be resolved. In this review, the authors summarize the current knowledge about genitourinary candidiasis. read more
